“A holiday from the facts.” That’s how the antagonist of “Brave New World” describes the wonder drug soma. The phrase might equally apply to U.S. marijuana policy. Since California first legalized ...

In a major change to federal marijuana policy, President Donald Trump signed an executive order in December to classify marijuana as a less dangerous substance. On Dec. 18, the president ordered the ...

U.S. drug policy is dictated by the Controlled Substances Act. The Controlled Substances Act categorizes drugs under different schedules and criteria. Classifying marijuana as a Schedule III drug ...

An investigational drug previously shown to improve wakefulness and reduce sleepiness in patients with narcolepsy type 1 (NT1) has now been linked to improved cognition. After 8 weeks of treatment, ...

Trump signed an executive order Thursday to reclassify marijuana to Schedule III. The change would ease federal restrictions but not legalize it nationwide. Experts say it could cut costs for ...

Aaron Navarro is a CBS News digital reporter. He covered the 2024 elections and was previously an associate producer for the CBS News political unit in the 2021 and 2022 election cycles. Washington — ...

President Donald Trump said Monday that the White House is “very strongly” considering signing an executive order to reschedule marijuana to a lower drug classification, which would ease federal ...

President Donald Trump is considering an executive order aimed at easing federal marijuana restrictions, according to reports by The Washington Post and CNBC, in a move that would make it easier to ...

A dramatic smash-and-grab burglary of a £270,000 Banksy print from a London gallery was captured on video. Larry Fraser, 49, of Evelyn Denington Road, Beckton, has been sentenced to 13 months in ...

The Pentagon is moving some of its most advanced units and weapons closer to Venezuela as tensions run high between President Trump and Nicolás Maduro. WSJ’s Shelby Holliday maps the buildup in the ...

Incyte’s decision to scrap work on its BET inhibitor program has not surprised analysts, who pointed to safety concerns overshadowing the drug class. The biopharma, which markets Novartis-partnered ...

There is no biological measure for wakefulness. In a narcolepsy clinical trial, a patient lies down in a dark lab while clinicians count the minutes until sleep comes. The average time in four tests ...